The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

Summit Therapeutics' ivonescimab poised for FDA approval, with the potential to disrupt the oncology market. Read more on ...

A bounding pulse is when your heart beats strongly. You may feel your pulse in your neck, wrist, or foot. Here’s why it ...

The event will pave the way for new commitments from First Ladies, ministers, and the Merck Foundation team to create more ...

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...

We anticipate a profitable buying opportunity for investors in Merck stock following a 15% decline in July. See why we ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA announced it has awarded $20,000 in scholarships to two ...

Westcoast Black Theatre Troupe announced its 2024-2025 Board of Trustees, with Doris A. Johnson continuing as Board Chair and ...

Mark Cuban, Barry Diller and James Murdoch among the prominent business world figures backing Kamala Harris' bid for the ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Even professional economists sometimes get it wrong ... strong revenue and earnings while sustaining its dividend payouts. Merck is also a leading drugmaker. The company's top-selling drug ...

Even professional economists sometimes get it wrong ... AbbVie (NYSE: ABBV) and Merck (NYSE: MRK). There is a good reason healthcare is considered a defensive industry. Many medical products ...